Apoptotic synergism between STI571 and the farnesyl transferase inhibitor SCH66336 on an imatinib-sensitive cell line
- 1 March 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (5) , 2070
- https://doi.org/10.1182/blood-2002-09-2980
Abstract
I have read the very interesting and informative article of Hoover et al,[1][1] which may open new avenues in treating imatinib-refractory and imatinib-sensitive chronic myeloid leukemia (CML). However, when testing the synergic potential of STI + farnesyl transferase inhibitor (FTI) combination onKeywords
This publication has 2 references indexed in Scilit:
- Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336Blood, 2002
- The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivoCancer Chemotherapy and Pharmacology, 2000